Screen the entire global market — including names the crowd has left for dead — by quality, growth, returns and valuation.
Every subsector ranked on valuation, income, returns and leverage, computed from our own company financials with a book-value NAV proxy. Click a subsector for its full report.
The financials and ratios on this page come straight from the filings and are live. The judgement — what it is worth, and what would break it — is what we add.
A fast read of the filings to help decide whether this is worth a closer look. Thin by design.
See plansA full research report on the company and everything around it — the filings, the competitors, the news, the industry, the economy and the regulatory backdrop — with a full valuation model, fair value, and bear, base and bull case scenarios.
Buy the deep research · $99Put a question to the analyst and get an answer grounded in this company's own filings and our research — "what breaks the thesis?", "how much of profit goes to interest?"
Included from Premium →It takes up to 3 hours and covers the filings, the competitors, the news, the wider industry, the economy it sits in, the regulatory backdrop, and a full model and a fair value with sensitivities. It runs in the background — we will let you know when it lands, so you do not need to keep this page open.
Annual financial statements as reported, going back as far as the data allows.
| $m | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E |
|---|
| $m | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E |
|---|
| $m | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E |
|---|
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E |
|---|
Who bought and sold, at what price, and how much of their own holding it was — from SEC Form 4 and UK PDMR notifications, with each insider's last-reported position and disclosed major holders.
A valuation is produced by the company research pipelines — the flash thesis carries one, and a deep dive replaces it with a fuller model. Neither has run for this company yet.
The 6 investable Specialty Chemicals industry peers closest in size, largest first. Market caps are shown in USD so the set compares like with like; the multiples are currency-neutral. The median is taken across the PEERS only — it is what this company is being compared to — and per column, over the peers that actually report each measure.
| Company | Mkt cap (USD) | P/E | EV/FCF | P/B | ROIC | Op margin | Div yield |
|---|---|---|---|---|---|---|---|
| Solstice Advanced Materials SOLS | $10.1bn | 48.2× | 97.1× | 7.2× | 10.0% | 16.6% | 13.1% |
| Evonik Industries EVK | $10.1bn | 55.2× | 11.8× | 0.96× | 2.7% | 3.8% | 4.3% |
| Guangzhou Tinci Materials Technology 002709 | $9.7bn | 22.6× | 124.4× | 3.6× | 7.8% | 9.6% | 0.9% |
| Hubei Dinglong Chemical 300054 | $9.6bn | 77.9× | 166.7× | 12.4× | 13.2% | 24.8% | 0.2% |
| Westlake Chemical WLK | $9.6bn | — | — | 1.1× | -10.2% | -14.1% | — |
| Hengyi Petrochemical 000703 | $9.5bn | 28.9× | — | 2.6× | 3.8% | 2.9% | 27.1% |
| Shandong Sinocera Func Material 300285 | $9.3bn | 100.6× | 154.6× | 8.7× | 11.5% | 19.1% | 0.3% |
| Peer median | $9.6bn | 48.2× | 110.7× | 3.1× | 5.8% | 6.7% | 4.3% |
A comparable set says what the market is paying for similar businesses today, not what any of them is worth. It is a cross-check on the model above, not a substitute for it.
A full deep-dive (business, moat, risks, valuation and scenarios) hasn't been generated for this company yet.
Source documents straight from the database — click to read the raw filing or release. Our read on what matters lives in Recent developments.
The issuer's own releases and dated events, newest first. The raw source documents live in Filings; our read on what matters lives in Recent developments.
Upcoming and recent investor events — results, AGM, dividend and ex-dividend dates — from the company's own investor calendar.
Every place this issuer trades — the home listing, foreign cross-listings and depositary receipts (ADR/CDR/BDR), plus any separate share classes. The screener shows one canonical line per company; the rest live here.
| Listing | Exchange | Ticker | Currency | Price | Type |
|---|
Interactive price chart with the common technical-analysis overlays and indicators — moving averages, Bollinger Bands, volume, RSI and MACD — plus an at-a-glance momentum summary. Use the chart's own toolbar to add or remove studies, change timeframe, or search a different listing.
A note on method: PrimerIQ's research is built bottom-up from the filings — what a business earns and what it's worth. The charts below read price history, not the business; we include them because many investors want them, not because they drive our valuation. Treat them as one lens among several.
Relative strength percentile: 91 vs market, 89 vs industry. Momentum rank is a 0–100 percentile across 36,468 companies — one lens, not a valuation signal.
Charts and technical data by TradingView. Not investment advice.
The webcast audio itself, transcribed in full, with the structural signals the transcript text alone loses — how scripted rather than spontaneous the language is, where management hesitated longest, and which answers were most hedged.
Included from Premium →Select a filing on the left to read it here.
Select a filing to view its raw text.